Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway. - Lin K; Rong Y; Chen D; Zhao Z; Bo H; Qiao A; Hao X; Wang J (Frontiers in oncology, 2020)